Updated:
Ocama Partners
Ocama Partners functions as a single-family office headquartered in San Juan, Puerto Rico. No public record discloses the founding year or the specific family...
Ocama Partners
Ocama Partners functions as a single-family office headquartered in San Juan, Puerto Rico. No public record discloses the founding year or the specific family branch behind the capital. The firm maintains a private investment vehicle structure centered on mental health advancements. The office targets Cannabis & Psychedelics, Digital Health, and Healthcare Services. It executes via direct co-investments and SPVs rather than broad fund commitments. Confirmed positions include Delix Therapeutics (Series A, 2021) and Sensorium Therapeutics (Series A, 2022). All activity remains within North America. Team details stay limited. Lourenço Bustani appears as Principal and Kevin as Partner. No additional offices, headcount, or adjacent vehicles appear in public materials. No operational event from the last 24 months is recorded. The structure centers on a narrow mandate that aligns family capital with psychedelic and biotech research vehicles. This produces repeated co-investor ties to specialist funds rather than broad LP commitments.
General information
Firm type
Single Family Office
Year founded
2021
Location
Region
North America
Country
Puerto Rico
City
San Juan
Corporate office
San Juan, Puerto Rico
Principals
Lourenço Bustani
Principal
Kevin
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Ocama Partners?
Lourenço Bustani serves as Principal. Kevin is listed as Partner. No additional decision-makers appear in public records.
Does Ocama Partners participate in fund commitments or only direct deals?
The firm executes through direct co-investments and SPVs. It joined Series A rounds for Delix Therapeutics in 2021 and Sensorium Therapeutics in 2022 alongside other venture investors.
What investment stages does Ocama Partners typically target?
Seed through Series B. Confirmed activity centers on Series A financings in biotech and psychedelics.
Which sectors does Ocama Partners focus on?
Cannabis & Psychedelics, Digital Health, and Healthcare Services. Technology emphasis includes AI/ML and Biotech.
Where does Ocama Partners invest geographically?
All disclosed activity occurs in North America.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: